Deschloroetizolam
- CAS NO.:40054-73-7
- Empirical Formula: C17H16N4S
- Molecular Weight: 308.4
- MDL number: MFCD02942552
- EINECS: 200-284-8
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-07-02 08:55:41
What is Deschloroetizolam?
Description
Deschloroetizolam is classified as a novel benzodiazepine. Benzodiazepines are central nervous system depressants. Novel benzodiazepines, typically defined as emergent benzodiazepines not used medicinally, are often pirated from early drug discovery or pharmaceutical studies. Novel benzodiazepines have appeared on illicit drug markets in recent years and have caused adverse events, as described in the literature.
The Uses of Deschloroetizolam
Dechloro Etizolam is a derivative of Etilozam (D226630) which is a a thienodiazepine benzodiazepine derivative. Etizolam has amnesic, anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. Etizolam is an anxiolytic related to that of the classic benzodiazepines. Etizolam has effect on monoamine metabolism in brain.
General Description
Deschloroetizolam, also known as Etizolam-2, is the dechlorinated analog of etizolam. Deschloroetizolam has been shown short-acting psychoactive effects and is sold as a designer drug with half the potency of its parent compound etizolam. It is not prescribed and is not recognized as a controlled substance in many parts of the world, leading to its appearance within grey market research chemical vendors in 2014. This certified Snap-N-Spike? solution standard is suitable for use in LC/MS or GC/MS benzodiazepine testing methods in clinical toxicology, urine drug testing, or forensic analysis.
Pharmacokinetics
Structurally, deschloroetizolam is a benzodiazepine. It is an analogue of etizolam, which is classified as a medicine, in that it has one less chloroatom in its benzene ring structure. The pharmacological effect of benzodiazepine is based on the molecule binding to the gamma-aminobutyric acid receptor (GABA) in the central nervous system. As a result of this binding, it will strengthen the effect of the GABA inhibitor. This will result in a nonspecific slowing down of the nerve paths, causing sedative, hypnotic, anxiolytic and anticonvulsant effects. The effect of benzodiazepine is targeted almost entirely at the central nervous system.
Regulatory Status
Legal status: Deschloroetizolam is classified and controlled as a hazardous substance in Sweden as of on October 15, 2015.
Regulations
Fatalities linked to novel benzodiazepine use have occurred, commonly when used in combination with other depressants (e.g. opioids and alcohol). The synthesis of deschloroetizolam dates back to at least the 1970’s based on previously published literature and patents. Deschloroetizolam was identified among the illicit drug supply in 2014 by scientists in the United Kingdom. Deschloroetizolam is structurally similar to etizolam. Neither substance is federally controlled in the United States, however, some states have moved to control etizolam. According to data from NPS Discovery, deschloroetizolam has been identified in at least ten toxicology samples since mid-2020.
Properties of Deschloroetizolam
Melting point: | 165-166 °C |
Boiling point: | 519.0±60.0 °C(Predicted) |
Density | 1.34±0.1 g/cm3(Predicted) |
storage temp. | -20°C |
solubility | DMF: 5 mg/ml DMSO: 5 mg/ml DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml Methanol: 1 mg/ml |
form | A crystalline solid |
pka | 2.45±0.40(Predicted) |
color | White to off-white |
λmax | 247 nm |
InChI | InChI=1S/C17H16N4S/c1-3-13-9-14-16(12-7-5-4-6-8-12)18-10-15-20-19-11(2)21(15)17(14)22-13/h4-9H,3,10H2,1-2H3 |
Safety information for Deschloroetizolam
Computed Descriptors for Deschloroetizolam
InChIKey | JIOBORXCOGMHSV-UHFFFAOYSA-N |
SMILES | N12C(C)=NN=C1CN=C(C1=CC=CC=C1)C1C=C(CC)SC=12 |
New Products
4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium THOMAIND PAPER PH 2.0 TO 4.5 1 BOX BUFFER CAPSULE PH 9.2 - 10 CAP SODIUM CHLORIDE 0.1N CVS ALLOXAN MONOHYDRATE 98% PLATINUM 0.5% ON 3 MM ALUMINA PELLETS (TYPE 73) LITHIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidYou may like
-
Deschloroetizolam solution CAS 40054-73-7View Details
40054-73-7 -
1-Methyl-6-oxo-1,6-dihydropyridazine-3-carbonitrile 98%View Details
99903-60-3 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%View Details
25408-95-1 -
2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%View Details
1805639-70-6 -
1784294-80-9 98%View Details
1784294-80-9 -
Lithium ClavulanateView Details
61177-44-4